India's Draft Drug Testing Rules Spark Debate Over Animal Lab Tests
Published
India has proposed new draft rules for how new medicines are tested before they reach the market. The rules concern the use of animals in laboratory tests, and they have started a discussion among scientists and drug experts. The draft guidelines focus on traditional animal testing methods, while some researchers want more attention given to non-animal testing methods.
Supporters of non-animal testing say that many drug candidates fail when they are tested on humans, even after they pass animal studies. This shows that the current methods may not always predict how a drug will work in people. Non-animal methods, such as laboratory models that use human cells and computer-based simulations, are becoming more common in many countries. Some experts believe that these methods could give more useful results for drug development and safety checks.
According to the report, the draft rules may give priority to certain scientific approaches that critics say are not the most reliable. These critics worry that the rules could slow down progress in newer testing technologies. Because the rules are still in draft form, the government has not yet made a final decision, and it is possible that changes will be made after public comments and expert feedback.
The debate matters for India because the country is a large producer of medicines and vaccines for both domestic and international markets. Decisions about drug testing can affect the cost of medicines, the speed of new drug approvals, and the safety of patients. Many readers will be watching to see whether the final rules balance animal welfare, scientific accuracy, and public health needs.
Sources: The Economic Times
More India news
- Cheaper Batteries Make Solar and Wind the Lowest-Cost Power Source in India, Says BNEF
- Why Money Flowing Out of India Is Drawing Attention
- Qualcomm Layoffs: What Severance Will Former Employees in India Receive?
- Suriya's Cop Comedy 'Scene' Earns Rs 111 Crore in Five Days at the Box Office
- Ajay Devgn's Drishyam 3: The Conclusion Passes Rs 588 Crore Worldwide After 40 Days
- Ramayana: Part 1 Continues Strong Box Office Run with Rs 440 Crore Collection
- Government Uses Online Marketplace to Buy Farm and Allied Sector Goods
- World Bank Estimates Extreme Poverty in India at 2.6 Per Cent, Sparking Debate